LifeMD Q1 revenue $50.2M beats guidance; adds 42k subscribers, record GLP-1 signups

LifeMD, Inc.

2026-Q1 EPS reported -$0.20 revenue$50,162,956

Revenue $50.2M vs guidance $48-49M; adj. EBITDA loss $4.5M in line.
Gross margin 88% (up ~420 bps YoY) on favorable mix & lower fulfillment costs.
Record GLP-1 new-patient revenues up ~120% QoQ; Women's Health signups up 657% QoQ with 70% lower CAC.
Subscribers exceeded 365k, net adds of 42k in Q1 (largest quarterly net addition).
Affirmed FY2026 revenue guidance $220-230M, adj. EBITDA $12-17M; cash $34.5M, no debt.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LifeMD, Inc. reported the first quarter ended March 31, 2026 results: revenue $50.2 million. Guidance reaffirmed.

Period: the first quarter ended March 31, 2026
Revenue: $50.2 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

2026. A copy of the press release is furnished herewith as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- LifeMD Reports First Quarter 2026 Results ● First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company’s guidance. ● Gross margin increased approximately 420 basis points to 88%, versus

View on SEC.gov

Browse all earnings releases →

LifeMD, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-021520

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.